Israel Discount Bank of New York’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,403
Closed -$688K 88
2022
Q1
$688K Sell
2,403
-442
-16% -$114K 0.45% 55
2021
Q4
$786K Sell
2,845
-1,384
-33% -$351K 0.49% 48
2021
Q3
$977K Buy
+4,229
New +$1.04M 0.66% 32
2021
Q1
$778K Sell
4,161
-482
-10% -$94.3K 0.6% 38
2020
Q4
$784K Sell
4,643
-1,378
-23% -$206K 0.57% 40
2020
Q3
$891K Sell
6,021
-187
-3% -$28.9K 0.58% 42
2020
Q2
$1.02M Sell
6,208
-1,035
-14% -$159K 0.69% 33
2020
Q1
$1M Buy
7,243
+2,239
+45% +$308K 0.77% 36
2019
Q4
$658K Buy
5,004
+2,561
+105% +$297K 0.43% 59
2019
Q3
$273K Buy
+2,443
New +$272K 0.2% 76
2019
Q1
Sell
-750
Closed -$87K 434
2018
Q4
$87K Hold
750
0.07% 127
2018
Q3
$80K Hold
750
0.05% 142
2018
Q2
$64K Hold
750
0.04% 210
2018
Q1
$58K Hold
750
0.04% 234
2017
Q4
$63K Hold
750
0.04% 222
2017
Q3
$64K Buy
+750
New +$61.5K 0.05% 220

Other funds holding LLY

Israel Discount Bank of New York's LLY Position: Q2 2022 in Review

Israel Discount Bank of New York sold out of Eli Lilly (LLY) in Q2 2022, closing a stake of 2,403 shares — an estimated $688K sold.

Israel Discount Bank of New York first reported a position in LLY in Q3 2017 and held it in 16 quarters. The position peaked at $1.02M in Q2 2020. 2,446 funds tracked by Wall St. Rank hold LLY as of Q2 2022.

  • Israel Discount Bank of New York reported no remaining Eli Lilly position as of Q2 2022 after selling out during the quarter.
  • Israel Discount Bank of New York sold 2,403 Eli Lilly shares in Q2 2022, an estimated $688K.
  • Israel Discount Bank of New York first reported a position in Eli Lilly in Q3 2017 and held it in 16 quarters.
  • Israel Discount Bank of New York's Eli Lilly position peaked at $1.02M in Q2 2020.
  • 2,446 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2022.

Based on Israel Discount Bank of New York's 13F filing for Q2 2022, filed 10 Aug 2022.